Trials / Completed
CompletedNCT05134064
68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer
68Ga-PSMA PET/CT Imaging in Assessment of PCa: Feasibility of Delayed Acquisition on Total-body PET/CT Scanner?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Dual-time point 68Ga-PSMA PET/CT could increase the lesion detection in PCa patients, it remains difficult to perform in clinical practice. The possibility of one-time point 68Ga-PSMA PET/CT imaging could be achieved using a total-body PET/CT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | total-body PET/CT | PCa patients who underwent PSMA PET/CT in our clinical center received two-time points scans at 1 h p.i. and 3 h p.i. on a total-body PET/CT scanner. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-07-31
- Completion
- 2021-08-31
- First posted
- 2021-11-24
- Last updated
- 2021-11-24
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05134064. Inclusion in this directory is not an endorsement.